184 related articles for article (PubMed ID: 38848939)
1. Probiotics and the reduction of SARS-CoV-2 infection through regulation of host cell calcium dynamics.
Endo HM; Bandeca SCS; Olchanheski LR; Schemczssen-Graeff Z; Pileggi M
Life Sci; 2024 Aug; 350():122784. PubMed ID: 38848939
[TBL] [Abstract][Full Text] [Related]
2. The emerging role of probiotics as a mitigation strategy against coronavirus disease 2019 (COVID-19).
Mirzaei R; Attar A; Papizadeh S; Jeda AS; Hosseini-Fard SR; Jamasbi E; Kazemi S; Amerkani S; Talei GR; Moradi P; Jalalifar S; Yousefimashouf R; Hossain MA; Keyvani H; Karampoor S
Arch Virol; 2021 Jul; 166(7):1819-1840. PubMed ID: 33745067
[TBL] [Abstract][Full Text] [Related]
3. Potential of targeting host cell calcium dynamics to curtail SARS-CoV-2 infection and COVID-19 pathogenesis.
Sultan F; Ahuja K; Motiani RK
Cell Calcium; 2022 Sep; 106():102637. PubMed ID: 35986958
[TBL] [Abstract][Full Text] [Related]
4. Dysregulation of host cell calcium signaling during viral infections: Emerging paradigm with high clinical relevance.
Saurav S; Tanwar J; Ahuja K; Motiani RK
Mol Aspects Med; 2021 Oct; 81():101004. PubMed ID: 34304899
[TBL] [Abstract][Full Text] [Related]
5. Probiotics: A potential immunomodulator in COVID-19 infection management.
Singh K; Rao A
Nutr Res; 2021 Mar; 87():1-12. PubMed ID: 33592454
[TBL] [Abstract][Full Text] [Related]
6. Probiotics-Derived Peptides and Their Immunomodulatory Molecules Can Play a Preventive Role Against Viral Diseases Including COVID-19.
Manna S; Chowdhury T; Chakraborty R; Mandal SM
Probiotics Antimicrob Proteins; 2021 Jun; 13(3):611-623. PubMed ID: 33226581
[TBL] [Abstract][Full Text] [Related]
7. Calcium Channel Blockers: A Possible Potential Therapeutic Strategy for the Treatment of Alzheimer's Dementia Patients with SARS-CoV-2 Infection.
Danta CC
ACS Chem Neurosci; 2020 Aug; 11(15):2145-2148. PubMed ID: 32662982
[TBL] [Abstract][Full Text] [Related]
8. COVID-19 influenced gut dysbiosis, post-acute sequelae, immune regulation, and therapeutic regimens.
Raj ST; Bruce AW; Anbalagan M; Srinivasan H; Chinnappan S; Rajagopal M; Khanna K; Chandramoorthy HC; Mani RR
Front Cell Infect Microbiol; 2024; 14():1384939. PubMed ID: 38863829
[TBL] [Abstract][Full Text] [Related]
9. Effect of probiotics as an immune modulator for the management of COVID-19.
Ray M; Manjunath A; Halami PM
Arch Microbiol; 2023 Apr; 205(5):182. PubMed ID: 37031431
[TBL] [Abstract][Full Text] [Related]
10. Role of probiotics to combat viral infections with emphasis on COVID-19.
Sundararaman A; Ray M; Ravindra PV; Halami PM
Appl Microbiol Biotechnol; 2020 Oct; 104(19):8089-8104. PubMed ID: 32813065
[TBL] [Abstract][Full Text] [Related]
11. The immunomodulatory effects of probiotics on respiratory viral infections: A hint for COVID-19 treatment?
Mahooti M; Miri SM; Abdolalipour E; Ghaemi A
Microb Pathog; 2020 Nov; 148():104452. PubMed ID: 32818576
[TBL] [Abstract][Full Text] [Related]
12. Probiotic supplementation: A prospective approach in the treatment of COVID-19.
Nayebi A; Navashenaq JG; Soleimani D; Nachvak SM
Nutr Health; 2022 Jun; 28(2):163-175. PubMed ID: 34747257
[No Abstract] [Full Text] [Related]
13. Probiotics, Photobiomodulation, and Disease Management: Controversies and Challenges.
Ailioaie LM; Litscher G
Int J Mol Sci; 2021 May; 22(9):. PubMed ID: 34066560
[TBL] [Abstract][Full Text] [Related]
14. Diet Supplementation, Probiotics, and Nutraceuticals in SARS-CoV-2 Infection: A Scoping Review.
Infusino F; Marazzato M; Mancone M; Fedele F; Mastroianni CM; Severino P; Ceccarelli G; Santinelli L; Cavarretta E; Marullo AGM; Miraldi F; Carnevale R; Nocella C; Biondi-Zoccai G; Pagnini C; Schiavon S; Pugliese F; Frati G; d'Ettorre G
Nutrients; 2020 Jun; 12(6):. PubMed ID: 32521760
[TBL] [Abstract][Full Text] [Related]
15. Probiotics/Prebiotics in Viral Respiratory Infections: Implication for Emerging Pathogens.
Heidari Z; Tajbakhsh A; Gheibihayat SM; Moattari A; Razban V; Berenjian A; Savardashtaki A; Negahdaripour M
Recent Pat Biotechnol; 2021 Oct; 15(2):112-136. PubMed ID: 33874878
[TBL] [Abstract][Full Text] [Related]
16. SARS-CoV-2 microbiome dysbiosis linked disorders and possible probiotics role.
Din AU; Mazhar M; Waseem M; Ahmad W; Bibi A; Hassan A; Ali N; Gang W; Qian G; Ullah R; Shah T; Ullah M; Khan I; Nisar MF; Wu J
Biomed Pharmacother; 2021 Jan; 133():110947. PubMed ID: 33197765
[TBL] [Abstract][Full Text] [Related]
17. Effects of yogurt containing probiotics on respiratory virus infections: Influenza H1N1 and SARS-CoV-2.
Jeon HY; Kim KS; Kim S
J Dairy Sci; 2023 Mar; 106(3):1549-1561. PubMed ID: 36631322
[TBL] [Abstract][Full Text] [Related]
18. Comparative Multiplexed Interactomics of SARS-CoV-2 and Homologous Coronavirus Nonstructural Proteins Identifies Unique and Shared Host-Cell Dependencies.
Davies JP; Almasy KM; McDonald EF; Plate L
ACS Infect Dis; 2020 Dec; 6(12):3174-3189. PubMed ID: 33263384
[TBL] [Abstract][Full Text] [Related]
19. SARS-CoV-2 attachment to host cells is possibly mediated via RGD-integrin interaction in a calcium-dependent manner and suggests pulmonary EDTA chelation therapy as a novel treatment for COVID 19.
Dakal TC
Immunobiology; 2021 Jan; 226(1):152021. PubMed ID: 33232865
[TBL] [Abstract][Full Text] [Related]
20. Probiotics: A gut response to the COVID-19 pandemic but what does the evidence show?
Brahma S; Naik A; Lordan R
Clin Nutr ESPEN; 2022 Oct; 51():17-27. PubMed ID: 36184201
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
